Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Shield Therapeutics
Shield Therapeutics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Accrufer
Ferric maltol
2019-07-25
2031-2035
Iron-deficiency anemia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Ferric maltol
deficiency diseases
,
crohn disease
,
hypertension
,
pulmonary hypertension
,
chronic renal insufficiency
,
kidney diseases
,
renal insufficiency
,
ulcerative colitis
,
colitis
,
ulcer
,
colorectal neoplasms
,
colonic neoplasms
,
iron-deficiency anemia
,
iron deficiencies
,
anemia
,
inflammatory bowel diseases
,
intestinal diseases
,
heart failure
,
infertility
,
aneuploidy
,
chalazion
,
non-small-cell lung carcinoma
,
lung neoplasms
,
adenocarcinoma of lung
Iron dextran
chronic hepatitis
,
hepatitis
,
hepatitis a
,
hepatitis b
,
chronic hepatitis b
,
anemia
,
hepatitis c
,
chronic hepatitis c
,
insulin resistance
,
neoplasm metastasis
,
iron-deficiency anemia
,
lymphatic diseases
,
iron deficiencies
,
chronic kidney failure
,
body weight
,
birth weight
Aspartame
healthy volunteers/patients
,
alzheimer disease
,
female genital neoplasms
,
melanoma
,
hepatitis b
,
chronic hepatitis b
,
depression
,
major depressive disorder
,
depressive disorder
,
lung neoplasms
,
triple negative breast neoplasms
,
pancreatic neoplasms
,
neoplasm metastasis
,
coronary disease
,
coronary artery disease
,
myocardial ischemia
,
heart diseases
,
chronic hepatitis
,
sickle cell anemia
,
adenocarcinoma
,
sarcoma
,
glioma
,
neuroblastoma
,
precursor cell lymphoblastic leukemia-lymphoma
,
parkinson disease
,
autistic disorder
,
autism spectrum disorder
,
pervasive child development disorders
,
rectal neoplasms
,
covid-19
,
pneumonia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
exanthema
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
stomach neoplasms
,
esophageal neoplasms
,
neoplasms
,
colorectal neoplasms
,
non-small-cell lung carcinoma
,
breast neoplasms
,
lupus nephritis
,
nephritis
,
large b-cell lymphoma diffuse
,
human influenza
,
anemia
,
leukemia
,
b-cell lymphoma
,
carcinoma
,
non-hodgkin lymphoma
,
myeloid leukemia acute
,
multiple sclerosis
,
sclerosis
,
hepatocellular carcinoma
,
colonic neoplasms
,
thrombocytopenic purpura idiopathic
,
thrombocytopenic purpura
,
purpura
,
liver cirrhosis
,
neuromyelitis optica
,
kidney diseases
,
membranous glomerulonephritis
,
chronic progressive multiple sclerosis
,
myeloid leukemia
,
nephrotic syndrome
,
nephrosis
,
lipoid nephrosis
,
recurrence
,
ovarian neoplasms
,
hemolysis
,
hemolytic anemia autoimmune
,
hemolytic anemia
,
hepatitis
,
hepatitis a
,
arthritis
,
hepatitis c
,
chronic hepatitis c
,
lymphoma
,
rheumatoid arthritis
,
juvenile arthritis
,
follicular lymphoma
,
syndrome
,
hiv infections
,
asthma
,
heart failure
,
myelodysplastic syndromes
,
preleukemia
,
acquired immunodeficiency syndrome
,
kidney transplantation
,
drug-related side effects and adverse reactions
,
heart disease risk factors
,
cognitive dysfunction
Nepidermin
head and neck neoplasms
,
squamous cell carcinoma of head and neck
,
non-small-cell lung carcinoma
,
lung neoplasms
,
squamous cell carcinoma
,
squamous cell neoplasms
,
colorectal neoplasms
,
carcinoma
,
breast neoplasms
,
ovarian neoplasms
,
triple negative breast neoplasms
,
endometrial neoplasms
,
uterine neoplasms
,
fallopian tube neoplasms
,
adenocarcinoma
,
malignant mesothelioma
,
ovarian epithelial carcinoma
,
mesothelioma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use